Events

CCEdit continues the mission to advance biotechnology innovation and translation into the clinic, and foster entrepreneurship in Slovenia. For this, we recently hosted Jernej Godec, Ph.D. a Senior Associate at Atlas Venture. Atlas Venture is a Cambridge, MA (USA)-based venture capital firm investing in innovative companies developing novel therapies. The firm has a long track …

Prof. Dr. Roman Jerala, Head of the Department of Synthesis Biology and Immunology at the Chemical Institute, succeeded in obtaining a new project of the European Research Council (ERC), titled CCEdit, to develop the use of the improved CRISPR system for gene knockout in the genome.This is an ERC Proof of Concept (PoC) grant, which is awarded …